A simple hybridoma screening method for high-affinity monoclonal antibodies using the signal ratio obtained from time-resolved fluorescence assay

被引:20
作者
Daigo, K
Sugita, S
Mochizuki, Y
Iwanari, H
Hiraishi, K
Miyano, K
Kodama, T
Hamakubo, T
机构
[1] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan
[2] Perseus Proteom Inc, Meguro Ku, Tokyo 1530041, Japan
关键词
high-affinity monoclonal antibody; hybridoma screening; time-resolved fluorescence assay; alpha-fetoprotein;
D O I
10.1016/j.ab.2005.12.007
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
In hybridoma screening, quantitative kinetic evaluation is difficult since the concentration of each antibody in the hybridoma Supernatant is unknown. From modeling calculations, we hypothesized that the ratio of two different antigen-antibody concentrations might allow discrimination of high-affinity monoclonal antibodies irrespective of the antibody concentration. Using anti-a-fetoprotein monoclonal antibodies of known affinity, we set the signal ratio of a time-resolved assay at > 0.1, in which the antigen concentrations were 10 and 100 ng/mL. From anti-a-fetoprotein hybridoma screening with this assay, it was possible to effectively select high-affinity monoclonal antibodies with K-D values below 1 X 10(-8) M. High-sensitivity sandwich enzyme-linked immunosorbent assay which detects domain III of alpha-fetoprotein has been established using selected high-affinity monoclonal antibodies. This screening method is useful for selection of high-affinity monoclonal antibodies of potential diagnostic value. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 27 条
[1]
Monoclonal antibody therapy of cancer [J].
Adams, GP ;
Weiner, LM .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1147-1157
[2]
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma [J].
Ainsworth, R ;
Bartlett, JMS ;
Going, JJ ;
Mallon, EA ;
Forsyth, A ;
Richmond, J ;
Angerson, W ;
Watters, A ;
Dunne, B .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (10) :1086-1090
[3]
Kinetic screening of antibodies from crude hybridoma samples using Biacore [J].
Canziani, GA ;
Klakamp, S ;
Myszka, DG .
ANALYTICAL BIOCHEMISTRY, 2004, 325 (02) :301-307
[4]
Carney Walter P, 2004, Clin Breast Cancer, V5, P105, DOI 10.3816/CBC.2004.n.014
[5]
ALPHA-FETOPROTEIN SYNTHESIS IN TRANSFORMED FETAL-RAT LIVER-CELLS [J].
CHOU, JY ;
SAVITZ, AJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (03) :844-851
[6]
ALPHA-FETOPROTEIN BIOSYNTHESIS AND HEPATOCELLULAR DIFFERENTIATION [J].
CHOU, JY ;
ITO, F ;
EVANS, G ;
CHIU, JF ;
FELDMAN, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) :1524-1530
[7]
The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker [J].
Cooke, T ;
Reeves, J ;
Lannigan, A ;
Stanton, P .
EUROPEAN JOURNAL OF CANCER, 2001, 37 :S3-S10
[8]
KINETIC AND AFFINITY LIMITS ON ANTIBODIES PRODUCED DURING IMMUNE-RESPONSES [J].
FOOTE, J ;
EISEN, HN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1254-1256
[9]
Selecting and screening recombinant antibody libraries [J].
Hoogenboom, HR .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1105-1116
[10]
Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology [J].
Huhtinen, P ;
Soukka, T ;
Lövgren, T ;
Härmä, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 294 (1-2) :111-122